1 Introduction to Research & Analysis Reports
    1.1 RNAi Medicine Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global RNAi Medicine Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global RNAi Medicine Overall Market Size
    2.1 Global RNAi Medicine Market Size: 2021 VS 2027
    2.2 Global RNAi Medicine Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top RNAi Medicine Players in Global Market
    3.2 Top Global RNAi Medicine Companies Ranked by Revenue
    3.3 Global RNAi Medicine Revenue by Companies
    3.4 Top 3 and Top 5 RNAi Medicine Companies in Global Market, by Revenue in 2020
    3.5 Global Companies RNAi Medicine Product Type
    3.6 Tier 1, Tier 2 and Tier 3 RNAi Medicine Players in Global Market
        3.6.1 List of Global Tier 1 RNAi Medicine Companies
        3.6.2 List of Global Tier 2 and Tier 3 RNAi Medicine Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global RNAi Medicine Market Size Markets, 2021 & 2027
        4.1.2 siRNA
        4.1.3 miRNA
        4.1.4 piRNA
        4.1.5 Others
    4.2 By Type - Global RNAi Medicine Revenue & Forecasts
        4.2.1 By Type - Global RNAi Medicine Revenue, 2016-2021
        4.2.2 By Type - Global RNAi Medicine Revenue, 2022-2027
        4.2.3 By Type - Global RNAi Medicine Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global RNAi Medicine Market Size, 2021 & 2027
        5.1.2 Drug Discovery & Development
        5.1.3 Therapeutics
        5.1.4 Drug Delivery
        5.1.5 Others
    5.2 By Application - Global RNAi Medicine Revenue & Forecasts
        5.2.1 By Application - Global RNAi Medicine Revenue, 2016-2021
        5.2.2 By Application - Global RNAi Medicine Revenue, 2022-2027
        5.2.3 By Application - Global RNAi Medicine Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global RNAi Medicine Market Size, 2021 & 2027
    6.2 By Region - Global RNAi Medicine Revenue & Forecasts
        6.2.1 By Region - Global RNAi Medicine Revenue, 2016-2021
        6.2.2 By Region - Global RNAi Medicine Revenue, 2022-2027
        6.2.3 By Region - Global RNAi Medicine Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America RNAi Medicine Revenue, 2016-2027
        6.3.2 US RNAi Medicine Market Size, 2016-2027
        6.3.3 Canada RNAi Medicine Market Size, 2016-2027
        6.3.4 Mexico RNAi Medicine Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe RNAi Medicine Revenue, 2016-2027
        6.4.2 Germany RNAi Medicine Market Size, 2016-2027
        6.4.3 France RNAi Medicine Market Size, 2016-2027
        6.4.4 U.K. RNAi Medicine Market Size, 2016-2027
        6.4.5 Italy RNAi Medicine Market Size, 2016-2027
        6.4.6 Russia RNAi Medicine Market Size, 2016-2027
        6.4.7 Nordic Countries RNAi Medicine Market Size, 2016-2027
        6.4.8 Benelux RNAi Medicine Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia RNAi Medicine Revenue, 2016-2027
        6.5.2 China RNAi Medicine Market Size, 2016-2027
        6.5.3 Japan RNAi Medicine Market Size, 2016-2027
        6.5.4 South Korea RNAi Medicine Market Size, 2016-2027
        6.5.5 Southeast Asia RNAi Medicine Market Size, 2016-2027
        6.5.6 India RNAi Medicine Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America RNAi Medicine Revenue, 2016-2027
        6.6.2 Brazil RNAi Medicine Market Size, 2016-2027
        6.6.3 Argentina RNAi Medicine Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa RNAi Medicine Revenue, 2016-2027
        6.7.2 Turkey RNAi Medicine Market Size, 2016-2027
        6.7.3 Israel RNAi Medicine Market Size, 2016-2027
        6.7.4 Saudi Arabia RNAi Medicine Market Size, 2016-2027
        6.7.5 UAE RNAi Medicine Market Size, 2016-2027
7 Players Profiles
    7.1 Alnylam Pharmaceuticals
        7.1.1 Alnylam Pharmaceuticals Corporate Summary
        7.1.2 Alnylam Pharmaceuticals Business Overview
        7.1.3 Alnylam Pharmaceuticals RNAi Medicine Major Product Offerings
        7.1.4 Alnylam Pharmaceuticals RNAi Medicine Revenue in Global (2016-2021)
        7.1.5 Alnylam Pharmaceuticals Key News
    7.2 Ionis Pharmaceuticals
        7.2.1 Ionis Pharmaceuticals Corporate Summary
        7.2.2 Ionis Pharmaceuticals Business Overview
        7.2.3 Ionis Pharmaceuticals RNAi Medicine Major Product Offerings
        7.2.4 Ionis Pharmaceuticals RNAi Medicine Revenue in Global (2016-2021)
        7.2.5 Ionis Pharmaceuticals Key News
    7.3 Suzhou Ribo Life Science Co.,Ltd.
        7.3.1 Suzhou Ribo Life Science Co.,Ltd. Corporate Summary
        7.3.2 Suzhou Ribo Life Science Co.,Ltd. Business Overview
        7.3.3 Suzhou Ribo Life Science Co.,Ltd. RNAi Medicine Major Product Offerings
        7.3.4 Suzhou Ribo Life Science Co.,Ltd. RNAi Medicine Revenue in Global (2016-2021)
        7.3.5 Suzhou Ribo Life Science Co.,Ltd. Key News
    7.4 Sirnaomics
        7.4.1 Sirnaomics Corporate Summary
        7.4.2 Sirnaomics Business Overview
        7.4.3 Sirnaomics RNAi Medicine Major Product Offerings
        7.4.4 Sirnaomics RNAi Medicine Revenue in Global (2016-2021)
        7.4.5 Sirnaomics Key News
    7.5 GemmaPharma
        7.5.1 GemmaPharma Corporate Summary
        7.5.2 GemmaPharma Business Overview
        7.5.3 GemmaPharma RNAi Medicine Major Product Offerings
        7.5.4 GemmaPharma RNAi Medicine Revenue in Global (2016-2021)
        7.5.5 GemmaPharma Key News
    7.6 RiboBio
        7.6.1 RiboBio Corporate Summary
        7.6.2 RiboBio Business Overview
        7.6.3 RiboBio RNAi Medicine Major Product Offerings
        7.6.4 RiboBio RNAi Medicine Revenue in Global (2016-2021)
        7.6.5 RiboBio Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer